On April 25, 2008, Actavis Totowa LLC, issued a Class I recall of Digitek® (digoxin), which is is a medication used to treat congestive heart failure, abnormal heart rhythms and other heart conditions. Digitek is manufactured by Actavis and was distributed by Mylan Pharmaceuticals Inc., and by UDL Laboratories, Inc.

Digitek was recalled due to the possibility that tablets were doubled in thickness and could contain twice the appropriate level of the active ingredient. According to a new release from Digitek’s manufacturer, digitalis toxicity “can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability, and bradycardia.” There have also been reports of digitalis toxicity leading to death. Our firm is currently investigating claims relating to Digitek. Chad Cook, one of the lawyers in our Mass Torts Section is handling those claims.

Other Related Articles

• More recalls of Digoxin
• Ethex Corporation Recalls Morphine Sulfate Tablets
• Prescription Drug Recall
• Medtronic Recall Issued for Sprint Fidelis Heart Leads After 5 People Die
• Medication Errors Are On The Increase